Pharma & Biotech Ondine Biomedical strikes deal with Mexico's largest private hospital network By Ian Lyall 5d
Medical technology & services Spire Healthcare agrees £1.03 billion takeover as management reshuffles By Ephrem Joseph 5d
Pharma & Biotech Incanthera signs exclusive skincare cream deal with LED device maker iSmart By Ian Lyall 5d
Insurance Standard Life operating profit jumps 25% staying on track for 2026 targets By Ephrem Joseph 5d
Financial Services Tech Bytes: Anthropic IPO could target US$2 trillion valuation as October launch takes shape By Proactive 5d
Oil & Gas Chariot, Metals One, Rome Resources, Connecting Excellence, Tap Global, Critical Mineral Resources By Stephen Gunnion 05/09
Pharma & Biotech Smith & Nephew keeps Jefferies 'buy' despite H2 growth scepticism By Ian Lyall 04/09
Hardware & electrical equipment Citi names key Apple supply chain gainers before iPhone 18 debut By Ian Lyall 04/09
Financial Services JPMorgan keeps Prudential at 'overweight' on cash conversion and buyback potential By Ian Lyall 04/09
Mining Cora Gold: Broker tweaks target, but remains upbeat as mine developer heads towards construction phase By Ian Lyall 04/09
Pharma & Biotech GSK's mRNA flu vaccine data closely tracks Moderna's, Deutsche Bank says By Ian Lyall 04/09
